Related Experiment Video

Updated: Aug 2, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Pathogenesis of pneumococcal inflammation: otitis media

E I Tuomanen1

  • 1St Jude Children's Research Hospital, 332 N. Lauderdale Road, Memphis, TN 38139, USA. elaine.tuomanen@stjude.org

Vaccine
|February 13, 2001
PubMed

Insights

Pneumococci cause ear damage via host responses to cell wall components and pneumolysin toxin. Understanding these inflammatory mechanisms is key to reducing otitis media complications.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • * *Streptococcus pneumoniae* (pneumococci) are a leading cause of otitis media and bacterial meningitis.
  • * Pathogenesis of pneumococcal-induced injury involves host immune responses to bacterial components and toxins.
  • * Antibiotic-induced lysis can exacerbate inflammation by releasing pneumococcal cell wall fragments.

Purpose of the Study:

  • * To elucidate the mechanisms of pneumococcal-induced inflammation in otitis media and meningitis.
  • * To define the signal transduction pathways involved in the host response to pneumococci.
  • * To identify targets for reducing the sequelae of pneumococcal infections.

Main Methods:

  • * Review of existing literature on pneumococcal pathogenesis.
  • * Analysis of host response pathways, including CD14, Toll-like receptor 2, NFkB, and cytokine production.
  • * Examination of pneumolysin's cytotoxic effects.

Main Results:

  • * Pneumococcal cell wall components trigger leukocyte influx and tissue injury.
  • * A defined signal transduction cascade involves CD14, TLR2, NFkB, and cytokine release.
  • * Pneumolysin, a pore-forming toxin, contributes significantly to cytotoxicity.

Conclusions:

  • * Understanding pneumococcal-induced inflammation is crucial for treating otitis media and meningitis.
  • * Targeting specific inflammatory pathways and toxins may mitigate disease severity.
  • * Further research into site-specific mechanisms is needed to reduce pneumococcal infection sequelae.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...